ID

35191

Description

A Study of Duvelisib in Combination With Rituximab or Obinutuzumab in Subjects With Previously Untreated CD20+ Follicular Lymphoma (CONTEMPO); ODM derived from: https://clinicaltrials.gov/show/NCT02391545

Link

https://clinicaltrials.gov/show/NCT02391545

Keywords

Versions (1)
  1. 2/23/19 2/23/19 -
Copyright Holder

See clinicaltrials.gov

Uploaded on

February 23, 2019

DOI

To request one please log in.

License

Creative Commons BY 4.0
Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Back to model comments
Itemgroup comments for :

Item comments for :

In order to download data models you must be logged in. Please log in or register for free.

Eligibility CD20+ Follicular Lymphoma NCT02391545

English

Eligibility CD20+ Follicular Lymphoma NCT02391545

1 forms  
Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
diagnosis of cd20+, follicular lymphoma that has not been treated
Description

Follicular Lymphoma CD20 positive Untreated

Data type

boolean

Alias
UMLS CUI [1,1]
C0024301
UMLS CUI [1,2]
C3888518
UMLS CUI [1,3]
C0332155
cd20-immunophenotyping of tumor to document b-cell follicular lymphoma
Description

CD20 Tumor immunophenotyping status | Lymphoma, Follicular

Data type

boolean

Alias
UMLS CUI [1,1]
C0054946
UMLS CUI [1,2]
C1300074
UMLS CUI [2]
C0024301
stage ii disease with bulky disease (≥ 7cm lesion), stage iii, or stage iv disease
Description

Disease Ann Arbor lymphoma staging system | Bulky Disease Lesion size

Data type

boolean

Alias
UMLS CUI [1,1]
C0012634
UMLS CUI [1,2]
C0432516
UMLS CUI [2,1]
C1511341
UMLS CUI [2,2]
C0449453
disease that requires treatment based on the investigator's opinion (e.g., meets gelf criteria)
Description

Disease Treatment required for

Data type

boolean

Alias
UMLS CUI [1,1]
C0012634
UMLS CUI [1,2]
C0332121
at least one measurable lesion that is > 1.5 cm in at least one dimension
Description

Measurable lesion | Lesion size Dimension Quantity

Data type

boolean

Alias
UMLS CUI [1]
C1513041
UMLS CUI [2,1]
C0449453
UMLS CUI [2,2]
C0439534
UMLS CUI [2,3]
C1265611
eastern cooperative oncology group (ecog) performance status <=2 (corresponds to karnofsky performance status [kps] >=60%)
Description

ECOG performance status | Karnofsky Performance Status

Data type

boolean

Alias
UMLS CUI [1]
C1520224
UMLS CUI [2]
C0206065
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
received systemic treatment for lymphoma such as chemotherapy, immunotherapy, radiotherapy, investigational agents, or radioimmunotherapy.
Description

Systemic therapy Lymphoma | Chemotherapy | Immunotherapy | Therapeutic radiology procedure | Investigational New Drugs | Radioimmunotherapy

Data type

boolean

Alias
UMLS CUI [1,1]
C1515119
UMLS CUI [1,2]
C0024299
UMLS CUI [2]
C0392920
UMLS CUI [3]
C0021083
UMLS CUI [4]
C1522449
UMLS CUI [5]
C0013230
UMLS CUI [6]
C0085101
clinical evidence of transformation to a more aggressive subtype of lymphoma or grade 3b follicular lymphoma
Description

Transformation Lymphoma Subtype Aggressive | Transformation Follicular Lymphoma Grade

Data type

boolean

Alias
UMLS CUI [1,1]
C0040682
UMLS CUI [1,2]
C0024299
UMLS CUI [1,3]
C0449560
UMLS CUI [1,4]
C0580822
UMLS CUI [2,1]
C0040682
UMLS CUI [2,2]
C0024301
UMLS CUI [2,3]
C0441800
severe allergic or anaphylactic reaction to any monoclonal antibody therapy, murine protein, or known hypersensitivity to any of the study drugs
Description

Severe allergic reaction Monoclonal Antibody Therapy | Anaphylactic reaction Severe Monoclonal Antibody Therapy | Severe allergic reaction Murine protein | Anaphylactic reaction Severe Murine protein | Hypersensitivity Investigational New Drugs

Data type

boolean

Alias
UMLS CUI [1,1]
C2220378
UMLS CUI [1,2]
C0279694
UMLS CUI [2,1]
C0002792
UMLS CUI [2,2]
C0205082
UMLS CUI [2,3]
C0279694
UMLS CUI [3,1]
C2220378
UMLS CUI [3,2]
C1699668
UMLS CUI [4,1]
C0002792
UMLS CUI [4,2]
C0205082
UMLS CUI [4,3]
C1699668
UMLS CUI [5,1]
C0020517
UMLS CUI [5,2]
C0013230
prior allogeneic hematopoietic stem cell transplant
Description

Allogeneic Hematopoietic Stem Cell Transplantation

Data type

boolean

Alias
UMLS CUI [1]
C1705576
prior, current or chronic hepatitis b or hepatitis c infection
Description

Hepatitis B | Hepatitis C | Hepatitis B, Chronic | Hepatitis C, Chronic

Data type

boolean

Alias
UMLS CUI [1]
C0019163
UMLS CUI [2]
C0019196
UMLS CUI [3]
C0524909
UMLS CUI [4]
C0524910
human immunodeficiency virus (hiv) infection or human t cell lymphotropic virus 1 (htlv-1) infection
Description

HIV Infection | HTLV-I Infection

Data type

boolean

Alias
UMLS CUI [1]
C0019693
UMLS CUI [2]
C0020097
Back to the top of the page

Similar models

Eligibility CD20+ Follicular Lymphoma NCT02391545

1 forms
Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
C1512693 (UMLS CUI)
Follicular Lymphoma CD20 positive Untreated
Item
diagnosis of cd20+, follicular lymphoma that has not been treated
boolean
C0024301 (UMLS CUI [1,1])
C3888518 (UMLS CUI [1,2])
C0332155 (UMLS CUI [1,3])
CD20 Tumor immunophenotyping status | Lymphoma, Follicular
Item
cd20-immunophenotyping of tumor to document b-cell follicular lymphoma
boolean
C0054946 (UMLS CUI [1,1])
C1300074 (UMLS CUI [1,2])
C0024301 (UMLS CUI [2])
Disease Ann Arbor lymphoma staging system | Bulky Disease Lesion size
Item
stage ii disease with bulky disease (≥ 7cm lesion), stage iii, or stage iv disease
boolean
C0012634 (UMLS CUI [1,1])
C0432516 (UMLS CUI [1,2])
C1511341 (UMLS CUI [2,1])
C0449453 (UMLS CUI [2,2])
Disease Treatment required for
Item
disease that requires treatment based on the investigator's opinion (e.g., meets gelf criteria)
boolean
C0012634 (UMLS CUI [1,1])
C0332121 (UMLS CUI [1,2])
Measurable lesion | Lesion size Dimension Quantity
Item
at least one measurable lesion that is > 1.5 cm in at least one dimension
boolean
C1513041 (UMLS CUI [1])
C0449453 (UMLS CUI [2,1])
C0439534 (UMLS CUI [2,2])
C1265611 (UMLS CUI [2,3])
ECOG performance status | Karnofsky Performance Status
Item
eastern cooperative oncology group (ecog) performance status <=2 (corresponds to karnofsky performance status [kps] >=60%)
boolean
C1520224 (UMLS CUI [1])
C0206065 (UMLS CUI [2])
Item Group
C0680251 (UMLS CUI)
Systemic therapy Lymphoma | Chemotherapy | Immunotherapy | Therapeutic radiology procedure | Investigational New Drugs | Radioimmunotherapy
Item
received systemic treatment for lymphoma such as chemotherapy, immunotherapy, radiotherapy, investigational agents, or radioimmunotherapy.
boolean
C1515119 (UMLS CUI [1,1])
C0024299 (UMLS CUI [1,2])
C0392920 (UMLS CUI [2])
C0021083 (UMLS CUI [3])
C1522449 (UMLS CUI [4])
C0013230 (UMLS CUI [5])
C0085101 (UMLS CUI [6])
Transformation Lymphoma Subtype Aggressive | Transformation Follicular Lymphoma Grade
Item
clinical evidence of transformation to a more aggressive subtype of lymphoma or grade 3b follicular lymphoma
boolean
C0040682 (UMLS CUI [1,1])
C0024299 (UMLS CUI [1,2])
C0449560 (UMLS CUI [1,3])
C0580822 (UMLS CUI [1,4])
C0040682 (UMLS CUI [2,1])
C0024301 (UMLS CUI [2,2])
C0441800 (UMLS CUI [2,3])
Severe allergic reaction Monoclonal Antibody Therapy | Anaphylactic reaction Severe Monoclonal Antibody Therapy | Severe allergic reaction Murine protein | Anaphylactic reaction Severe Murine protein | Hypersensitivity Investigational New Drugs
Item
severe allergic or anaphylactic reaction to any monoclonal antibody therapy, murine protein, or known hypersensitivity to any of the study drugs
boolean
C2220378 (UMLS CUI [1,1])
C0279694 (UMLS CUI [1,2])
C0002792 (UMLS CUI [2,1])
C0205082 (UMLS CUI [2,2])
C0279694 (UMLS CUI [2,3])
C2220378 (UMLS CUI [3,1])
C1699668 (UMLS CUI [3,2])
C0002792 (UMLS CUI [4,1])
C0205082 (UMLS CUI [4,2])
C1699668 (UMLS CUI [4,3])
C0020517 (UMLS CUI [5,1])
C0013230 (UMLS CUI [5,2])
Allogeneic Hematopoietic Stem Cell Transplantation
Item
prior allogeneic hematopoietic stem cell transplant
boolean
C1705576 (UMLS CUI [1])
Hepatitis B | Hepatitis C | Hepatitis B, Chronic | Hepatitis C, Chronic
Item
prior, current or chronic hepatitis b or hepatitis c infection
boolean
C0019163 (UMLS CUI [1])
C0019196 (UMLS CUI [2])
C0524909 (UMLS CUI [3])
C0524910 (UMLS CUI [4])
HIV Infection | HTLV-I Infection
Item
human immunodeficiency virus (hiv) infection or human t cell lymphotropic virus 1 (htlv-1) infection
boolean
C0019693 (UMLS CUI [1])
C0020097 (UMLS CUI [2])
Back to the top of the page 

Contact

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Help

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial